Yu-Jie Liu

Mr. Yu-Jie Liu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2023 in Journal of Lipid Research
Verified
Journal Article
Open access
HWHai-Peng Wang
Hai-Peng Wang
NZNa Zhang
Na Zhang
YLYu-Jie Liu
Yu-Jie Liu
TXTian-Long Xia
Tian-Long Xia
Guochong ChenGuochong Chen
Guochong Chen
FLFurong Li
Furong Li
Lipoprotein(a) (Lp(a)) is a largely genetically determined biomarker for cardiovascular disease (CVD), while its potential interplay with family history (FHx) of CVD, a measure of both genetic and environmental exposures, remains unclear. We examined the associations of Lp(a) in terms of circulating concentration or polygenetic risk score (PRS), and FHx of CVD with risk of incident heart failure (HF). Included were 299,158 adults from the UK Biobank without known HF and CVD at baseline. Hazards ratios (HRs) and 95% Cls were estimated by Cox regression models adjusted for traditional risk factors defined by the Atherosclerosis Risk in Communities study HF risk score. During the 11.8-year follow-up, 5,502 incidents of HF occurred. Higher levels of circulating Lp(a), Lp(a) PRS, and positive FHx of CVD were associated with higher risks of HF. Compared with individuals who had lower circulating Lp(a) and no FHx, HRs (95% CIs) of HF were 1.36 (1.25, 1.49), 1.31 (1.19, 1.43), and 1.42 (1.22, 1.67) for those with higher Lp(a) and a positive history of CVD for all family members, parents, and siblings, respectively; similar results were observed by using Lp(a) PRS. The risk estimates for HF associated with elevated Lp(a) and positive FHx were attenuated after excluding those with incident myocardial infarction (MI) during follow-up. Lp(a) and FHx of CVD were independent risk factors for incident HF, and the highest risk of HF was observed among individuals with both risk factors. The association may be partly mediated by myocardial infarction.

20 March 2024 in Clinical Nutrition
Verified
Journal Article
Closed access
YLYu-Jie Liu
Yu-Jie Liu
FLFu-Rong Li
Fu-Rong Li
WHWen-Wen Han
Wen-Wen Han
YLYan Liu
Yan Liu
YLYu Liu
Yu Liu
Guochong ChenGuochong Chen
Guochong Chen

17 March 2023 in Toxics
Verified
Journal Article
Open access
PDF file
TWTian-Ci Wang
Tian-Ci Wang
LZLiming Zhang
Liming Zhang
YLYu-Jie Liu
Yu-Jie Liu
JLJian Li
Jian Li
GCGuochong Chen
Guochong Chen
JCJingsi Chen
Jingsi Chen
[Background] Metal exposure is suspected to be correlated to kidney function. However, the combined effects of co-exposing to multiple metals, especially both toxic and protective metals, have not been completely evaluated. [Method] A prospective cohort study was conducted with the “135” cohort for the evaluation of how plasma metal levels are correlated to kidney function in a midlife and elderly community in southern China. An amount of 1368 subjects without kidney disease at baseline were enrolled in the final analysis. By using linear regression and logistic regression models, the correlation of individual metal values with renal function parameters was assessed. Measuring of the multiple metal exposure level was performed by principal component analysis (PCA). [Results] Diminished renal function, as evaluated based on fast kidney function decline, or estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, was positively associated with the plasma concentrations of chromium and potassium, but it was negatively associated with selenium and iron (p < 0.05). In multiple-metal analyses, linear and logistic regression models showed that the iron and chromium exposure pattern had a protective effect on renal function, whereas the sodium and potassium exposure pattern and the cadmium and lead exposure pattern increased the risk for fast kidney function decline, and eGFR < 60 mL/min/1.73 m2. [Conclusions] Certain metals, including chromium, potassium, selenium, and iron, were correlated with kidney function in a midlife and elderly community in China. In addition, the potential combined influences of co-exposing to multiple metals were observed.

16 December 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
WHWen‐Wen Han
Wen‐Wen Han
JGJi‐Mei Gu
Ji‐Mei Gu
YQYu‐Wen Qian
Yu‐Wen Qian
JZJun‐Yu Zhao
Jun‐Yu Zhao
XSXiao‐Ping Shao
Xiao‐Ping Shao
Guochong ChenGuochong Chen
Guochong Chen
Background: Chronic kidney disease (CKD) is associated with early menopause, and thereby reduced endogenous estrogen exposure (EEE) and elevated risk of cardiovascular disease (CVD). Methods: Included were 138 154 naturally menopausal and 63 542 nonmenopausal women from the UK Biobank. To reflect cumulative EEE, duration of EEE was estimated as the time interval between age at menarche and current age (for nonmenopausal women) or age at menopause (for menopausal women). The relationship of menopausal status with incident CVD were assessed by CKD status, further considering cumulative EEE. Results: Menopausal and nonmenopausal women had a comparable risk of CVD after accounting for age. Menopausal status interacted with CKD on risk of CVD ( P for interaction=0.001). In the CKD group, menopausal women had a lower risk of CVD than nonmenopausal women (hazard ratio [HR], 0.75 [95% CI, 0.58–0.97]), predominantly for those with EEE ≥38 years (HR, 0.64 [95% CI, 0.47–0.88]) but not for those with shorter EEE (HR, 1.00). In the non‐CKD group, being menopausal was not associated with risk of CVD (HR, 1.00), but was associated with a suggestively lower risk among those with longer EEE (HR, 0.90 [95% CI, 0.81–1.00]) and a higher risk among those with shorter EEE (HR, 1.13 [95% CI, 1.02–1.25). Conclusions: The association of menopausal status with risk of CVD appears to be varied by CKD status and further influenced by cumulative exposure to endogenous estrogen. These findings may have implications for more individualized CVD risk stratification and prevention in menopausal women.

1 May 2023 in Journal of Diabetes
Verified
Journal Article
Open access
YLYu-Jie Liu
Yu-Jie Liu
FLFu‐Rong Li
Fu‐Rong Li
CCCai‐Long Chen
Cai‐Long Chen
ZWZhong‐Xiao Wan
Zhong‐Xiao Wan
JCJin‐Si Chen
Jin‐Si Chen
Guochong ChenGuochong Chen
Guochong Chen
BackgroundWhether estimated glomerular filtration rates (eGFRs) by differing biomarkers are differentially associated with mortality or whether the associations differ by diabetes status remains unclear, especially in Chinese population. MethodsWe included 6995 participants without diabetes (mean age: 60.4 years) and 1543 with diabetes (mean age: 61.8 years). Each eGFR measure was divided into normal (>= 90 mL/min/1.73 m(2)), modestly declined (60 to <90 mL/min/1.73 m(2)), and chronic kidney disease (CKD) (<60 mL/min/1.73 m(2)) groups. Cox proportional hazards models were used to estimate hazard ratio (HR) of all-cause mortality associated with each eGFR. ResultsOver a follow-up of 7 years, 677 and 215 deaths occurred among individuals without or with diabetes, respectively. Among those without diabetes, all measures of modestly declined eGFR were not associated with mortality, whereas CKD defined by eGFR cystatin C (eGFRcys) and eGFR creatinine (eGFRcr)-cys (HRs were 1.71 and 1.55, respectively) but not by eGFRcr were associated with higher risk of mortality. Among diabetes, all measures of modestly declined eGFR (HRs: 1.53, 1.56, and 2.09 for eGFRcr, eGFRcys, and eGFRcr-cys, respectively) and CKD (HRs: 2.57, 2.99, and 3.92 for eGFRcr, eGFRcys, and eGFRcr-cys, respectively) were associated with higher risk of mortality. Regardless of diabetes status, an addition of eGFRcys or eGFRcr-cys to traditional risk factors lead to a larger improvement in the prediction of all-cause mortality risk than adding eGFRcr. ConclusionsThe association of eGFR with mortality risk appeared to be varied by its measures and by diabetes status among middle-aged and older Chinese, which needs to be considered in clinical practice.